One of India’s fastest growing homegrown research-oriented pharmaceutical companies, Gujarat-based Asprius Lifesciences, has achieved a milestone in the treatment of Diabetic Neuropathy, a condition that causes nerve damage in peripheral areas of the body, leading to symptoms like weakness, numbness and acute pain in hands and feet.